Published in Cancer Weekly, July 24th, 2007
Dr. Hulse also is a member of the Board of Directors at Battelle, a $3 billion annual revenue global science and technology enterprise that develops and commercializes technology and manages laboratories for customers.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.